Addressing the Spectrum of Platinum-Resistant Ovarian Cancer: Newer and Emerging Targeted Therapies

Addressing the Spectrum of Platinum-Resistant Ovarian Cancer: Newer and Emerging Targeted Therapies

– Summarize the shifting paradigm associated with platinum resistance in patients with ovarian cancer, including its burden and impact on patient QoL and outcomes Assess the mechanisms of action, most recent clinical data, and therapeutic implications associated with newer and emerging agents for patients with recurrent PROC Develop comprehensive patient-centered treatment plans that incorporates patient goals, AE management, psychological concerns, and clinical trial participation

  • Provider:HMP Education
  • Activity Link: https://www.hmpeducation.com/program/24gduwo1021
  • Start Date: 2024-12-02 06:00:00
  • End Date: 2024-12-02 06:00:00
  • Credit Details: AAPA Category 1 Credit™️: 0.75 hours
    AMA PRA Category 1 Credit™️: 0.75 hours
    Nursing: 0.75 hours
    Pharmacy: 0.75 hours
  • MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: General Surgery
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.